t(6;12)(p21;p13) G-banding.
Identity
t(6;12)(p21;p13) G-banding.
Clinics and pathology
Disease t(6;12)(p21;p13) has been described in only 6 cases: chronic lymphocytic leukemia (CLL); acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma ; acute myeloid leukemia (AML), NOS; myelodysplastic syndrome (MDS), RAEB-2 ; and breast adenocarcinoma.
Phenotype / cell stem origin B lineage.
Prognosis
No prognosis value established.
Cytogenetics

Cytogenetics morphological
May be not easy to detect.
Cytogenetics molecular
In CLL, the translocation was detected by FISH with ETV6 probes. The ETV6 gene is rearranged, and the breakpoint is between exon 1 and exon 2.
Additional anomalies -9 and der(16)t(9;16)(q21;q24) in CLL; and del(7)(p13p22) in ALL.
Variants
No variants in CLL and ALL.
Genes involved and Proteins
ETV6
Location: 12p13 Note: The gene is known to be involved in a large number of chromosomal rearrangements associated with leukemia and congenital fibrosarcoma. DNA / RNA 9 exons; alternate splicing. Protein The gene encodes an ETS family transcription factor; the product of this gene contains a N-terminal pointed (PNT) domain that is involved in the protein-protein interactions, and a C-terminal ETS DNA-binding domain; wide expression; nuclear localization.
CCND3 (cyclin D3)
Location: 6p21 Note: Could be the putative gene involved on 6p21. No molecular studies on 6p21 are described in cases with t(6;12). In t(6;14)(p21;q32), the breakpoint is centromeric to the CCND3 gene, causing dysregulation and overexpression of CCND3.
Results of the chromosomal anomaly
Fusion protein
Description
In CLL the ETV6 gene is rearranged; the breakpoint in ETV6 is between exon 1 and exon 2.
